NWPF

News ArchivesRead News

Doctors Unravel The Placebo Effect Of Fake Parkinson's Disease Treatment

Friday July 18, 2014

Ben Wolford

Medical Daily - In a new study examining patients with advanced Parkinson's disease, neurologists say they've identified parts of the brain that control placebo effect, raising hopes of singling out people most susceptible.

But they're still very much in the dark about underlying causes of one of medicine's great mysteries. Some people, when given fake treatment, actually get better, but others, for whatever reason, do not. Stranger still, some people improve at the mere suggestion of future treatment.

The placebo effect is a problem for clinical researchers because they need to know which treatments work and which don't. When people respond well to treatments they aren't actually given or that don't actually work, it skews the results. That's why, for years, doctors have been trying to figure out how placebo works and why.

"While they may appear to be mysterious, placebo responses have discernible neurophysiological mechanisms," wrote the authors of a companion commentary inThe Journal of Clinical Investigation. To learn more about those mechanisms, neuroscientists at the Feinstein Institute for Medical Research in New York chose 45 patients with Parkinson's disease for a double-blind study. All of them would receive brain surgery, but only 22 would receive actual treatment. The other 23 were given fairly routine operations designed to do nothing.

The doctors weren't looking for signs of placebo effect — they already knew it would happen. Patients with Parkinson's disease, the second most common neurological illness behind Alzheimer's, have previously shown an incredible sensitivity to the idea of treatment. A 2001 study illustrated that dopamine released at the expectation of possible healing had healing benefits by itself. "Expectations," doctors wrote in another study, "have a strong influence on the subsequent emotional experience of both" pain relief and reward processing.

Here's the interesting thing: Those 16 patients had very little activity before surgery in the parts of the brain that are activated by placebo. The other seven had more activity in the region all along. So that's the good thing — research doctors may now have something to look for when they want to weed out placebo-receptive test patients.

The bad thing is researchers still have no clue how a little dopamine and anti-depressant brain activity relates to improved motor function. "The final effector pathway remains obscure," wrote Mariya V. Cherkasova and A. Jon Stoessl in their commentary. But they say one thing is more clear from the study — expectation didn't have anything to do with it. The knowledge of participation in clinical trials did not induce placebo effect.

In a sad coda to the study, one year after their placebo brain surgeries, the Parkinson's patients were unblinded. That is, their doctors revealed that they had been in the sham surgery group and not the treatment group. Immediately, the parts of their brains that are activated by placebo reverted to their normal state. With that, their small gains in motor functioning disappeared, too.

Wolford, Ben. (18 July 2014). Medical Daily. Doctors Unravel The Placebo Effect Of Fake Parkinson's Disease Treatment. http://www.medicaldaily.com/doctors-unravel-placebo-effect-fake-parkinsons-disease-treatment-293760

Recent News

Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis